Intralesional collagenase <i>Clostridium histolyticum</i> vs. verapamil injections in males with Peyronie’s Disease: A prospective, matched-pair, non-blinded, randomised clinical study comparing clinical outcomes and patient satisfaction rates

Eric Chung, Juan Wang

Open source

DOI
10.4111/icu.20220145
Published
2022
Container
Investigative and Clinical Urology
Publisher
XMLink
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.4111/icu.20220145,
  title = {Intralesional collagenase <i>Clostridium histolyticum</i> vs. verapamil injections in males with Peyronie’s Disease: A prospective, matched-pair, non-blinded, randomised clinical study comparing clinical outcomes and patient satisfaction rates},
  author = {Eric Chung and Juan Wang},
  year = {2022},
  journal = {Investigative and Clinical Urology},
  doi = {10.4111/icu.20220145},
  url = {https://doi.org/10.4111/icu.20220145}
}

RIS

TY  - JOUR
TI  - Intralesional collagenase <i>Clostridium histolyticum</i> vs. verapamil injections in males with Peyronie’s Disease: A prospective, matched-pair, non-blinded, randomised clinical study comparing clinical outcomes and patient satisfaction rates
AU  - Eric Chung
AU  - Juan Wang
PY  - 2022
JO  - Investigative and Clinical Urology
DO  - 10.4111/icu.20220145
UR  - https://doi.org/10.4111/icu.20220145
ER  - 

APA

Chung, E., & Wang, J. (2022). Intralesional collagenase <i>Clostridium histolyticum</i> vs. verapamil injections in males with Peyronie’s Disease: A prospective, matched-pair, non-blinded, randomised clinical study comparing clinical outcomes and patient satisfaction rates. Investigative and Clinical Urology. https://doi.org/10.4111/icu.20220145

Source records